HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

2012130 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Neuro-Oncology

Volume 110, Issue 3, pp. 335-348

Field-Weighted Citation Impact: 2.68